Macular infarction after intravitreal amikacin.
A case of macular infarction after intravitreal amikacin was observed in a patient with postoperative endophthalmitis. A review of the literature revealed no previously documented case occurring after intravitreal amikacin. Suggestions to avoid such a complication in an otherwise recovered patient are discussed. Also, better alternatives to intravitreal aminoglycosides should be sought.
Kumar
H
H
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
Ahuja
S
S
Kumar
A
A
D000583:Amikacin / Q000009:adverse effects* / Q000627:therapeutic use; D002387:Cataract Extraction / Q000009:adverse effects; D009877:Endophthalmitis / Q000188:drug therapy / Q000209:etiology; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D007238:Infarction / Q000139:chemically induced*; D007267:Injections; D007910:Lenses, Intraocular / Q000009:adverse effects; D008266:Macula Lutea / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D014822:Vitreous Body
D000583:Amikacin